Header
Header
Article

New patent for Teva Pharm drug ARMONAIR DIGIHALER – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug ARMONAIR DIGIHALER


Annual Drug Patent Expirations for ARMONAIR+DIGIHALER

Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty patents protecting this drug.

Drug patent litigation for ARMONAIR DIGIHALER.

The generic ingredient in ARMONAIR DIGIHALER is fluticasone propionate. One supplier is listed for this compound. Additional details are available on the fluticasone propionate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug ARMONAIR DIGIHALER



Source link

Back to top button